Boston Scientific (BSX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $5.44 billion versus the consensus estimate of $5.37 billion.
GUIDANCE:
Boston Scientific sees FY2026 EPS of $3.28-$3.32, versus the consensus of $3.36.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exlservice (EXLS) PT Raised to $48 at Stifel
- Stagwell Inc (STGW) Tops Q3 EPS by 3c ; Offers Guidance
- UBS Reiterates Buy Rating on O'Reilly Automotive (ORLY)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
